Brief: Lixte Biotechnology Holdings Inc Collaboration With Netherlands Cancer Institute And Oncode Institute To Identify Promising Drugs To Be Combined With LB-100
Oct 13 (Reuters) - Lixte Biotechnology Holdings Inc
LIXT.O :
* LIXTE BIOTECHNOLOGY - COLLABORATION WITH NETHERLANDS
CANCER
INSTITUTE AND ONCODE INSTITUTE TO IDENTIFY PROMISING DRUGS TO BE
COMBINED WITH LB-100
Source text for Eikon: ID:nGNX9KkzFR
Further company coverage: LIXT.O
Recent news on NOMAD Power Solutions
See all newsBrief: Nomad Power Solutions Files 2026 Second Quarter Form 10-Q, Provides Business Update
U.S. STOCKS ON THE MOVE-SpaceX, Tesla, Woodside Energy Group
U.S. STOCKS ON THE MOVE-SpaceX, SharonAI, Medline
U.S. STOCKS ON THE MOVE-SpaceX, SharonAI, Medline
LIXTE to buy battery firm NOMAD, shifts away from cancer drugs; shares rise